We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of proliferative lupus nephritis: a changing landscape.
- Authors
Adu, D.
- Abstract
Grootscholten et al. report a randomized controlled trial comparing azathioprine plus intravenous methylprednisolone and oral prednisolone (AZA group) with intermittent intravenous cyclophosphamide and oral prednisolone (CY group) in patients with proliferative lupus nephritis. AZA-treated patients were more likely to develop non-sustained doubling of their serum creatinine, although not significantly so, and significantly more likely to have a relapse of their nephritis than CY-treated patients.Kidney International (2006) 70, 616–618. doi:10.1038/sj.ki.5001722
- Subjects
LUPUS nephritis; KIDNEY diseases; CREATINE; THERAPEUTICS; PATIENTS; GLOMERULONEPHRITIS
- Publication
Kidney International, 2006, Vol 70, Issue 4, p616
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1038/sj.ki.5001722